Untuk Kegunaan UKM sahaja
For UKM use only
PEGAWAI SAINS
| Sarjana , UM , 2009 |
| Sarjana Muda dengan Kepujian , UKM , 2003 |
| Kha Chin Long, Norlela Sukor, Geok Chin Tan, Nor Azian Abdul Murad, Morris Jonathan Brown, Elena Aisha Azizan. (2023). Elucidating Effect Of Inhibiting Aldosterone Synthesis On Human Adrenocortical Cells. - Journal Of Hypertension. e362. |
| Noorasyikin Ma, Elena Aa, Teh Pc, Farah Waheeda T, Siti Hajar Md, Long Kc, Norlinah Mi. (2020). Oral Trehalose Maybe Helpful For Patients With Spinocerebellar Ataxia 3 And Should Be Better Evaluated. - Parkinsonism And Related Disorders. 42-44. |
| Geok Chin Tan, Giulia Negro, Alexandra Pinggera, Nur Maya Sabrina Tizen Laim, Isa Mohamed Rose, Jiri Ceral, Ales Ryska, Long Kha Chin, Nor Azmi Kamaruddin, Norfilza Mohd Mokhtar, A. Rahman A. Jamal, Norlela Sukor, Miroslav Solar, Joerg Striessnig, Morris. (2017). Aldosterone-producing Adenomas: Histopathology-genotype Correlation And Identification Of A Novel Cacna1d Mutation. - Hypertension. 129-136. |
| Kha Chin Long, Norlela Sukor, Geok Chin Tan, Nor Azian Abdul Murad, Morris Jonathan Brown, Elena Aisha Azizan. (2023). Elucidating Effect Of Inhibiting Aldosterone Synthesis On Human Adrenocortical Cells. - Journal Of Hypertension. e362. |
| Kha Chin Long, Norlela Sukor, Geok Chin Tan, Nor Azian Abdul Murad, Morris Jonathan Brown, Elena Aisha Azizan. (2022). Elucidating The Effects Of Mutations In Q209 Of Gna11 On Cell Apoptosis In Human Adrenocortical Cells. - Journal Of The Asean Federation Of Endocrine Societies. 21. |
| Noorasyikin Ma, Elena Aa, Teh Pc, Farah Waheeda T, Siti Hajar Md, Long Kc, Norlinah Mi. (2020). Oral Trehalose Maybe Helpful For Patients With Spinocerebellar Ataxia 3 And Should Be Better Evaluated. - Parkinsonism And Related Disorders. 42-44. |
| Norlinah Mohamed Ibrahim, Yue Hui Lau, Noorasyikin Ariffin, Siti Hajar Md Desa, Elena Azizan, Long Kha Chin, Shahrul Azmin Md Rani, Yusnita Yakob, Santhi Datuk Puvanarajah & Bart Van De Warrenburg. (2020). Frequency Of Spinocerebellar Ataxia Type 1, 2, 3, 6 And 7 And Clinical Profile Of Spinocerebellar Ataxia Type 3 In Malaysia. - Cerebellum And Ataxia. 1-4. |
| Elena Aisha Azizan, Kha Chin Long, Norlela Sukor, Ruhaya Salleh, Fatimah Othman, Thamil Arasu Saminathan, Xilin Wu, Junhua Zhou, Feng Jun He, Graham Mac Gregor, Morris Jonathan Brown. (2020). High Salt Intake May Paradoxically Drive Autonomous Aldosterone Production. - Journal Of The Endocrine Society. A925. |
| Geok Chin Tan, Giulia Negro, Alexandra Pinggera, Nur Maya Sabrina Tizen Laim, Isa Mohamed Rose, Jiri Ceral, Ales Ryska, Long Kha Chin, Nor Azmi Kamaruddin, Norfilza Mohd Mokhtar, A. Rahman A. Jamal, Norlela Sukor, Miroslav Solar, Joerg Striessnig, Morris. (2017). Aldosterone-producing Adenomas: Histopathology-genotype Correlation And Identification Of A Novel Cacna1d Mutation. - Hypertension. 129-136. |
| Raja Affendi Bin Raja Ali;long Kha Chin;wong Zhiqin;chew Chia Hsin Deborah;khairul Najmi Bin Muhammad Nawawi. (2023). A Long-term Extension Study To Evaluate The Safety Of Filgotinib In Subjects With Ulcerative Colitis. - . . |
| Norlaila Binti Mustafa;hartini Bt. Mohtar;nurul Hani Bt. Mat;zahara Binti Abdul Manaf;rabizah Binti Md. Zain;amiliyaton Binti Mohd Razali;fauziah Binti Bharum;norasyikin Binti A. Wahab @ A. Rahman;noradila Binti Zainuddin;samirah Taufiq Binti Abdul Wahid;. (2023). A Randomized Controlled Trial To Determine The Effects Of Diabetes-specific Formula On Glycemic Control In Individuals With Type 2 Diabetes. - . . |
| A Phase IIb/III, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of cotadutide in participants with non-cirrhotic non-alcoholic steatohepatitis with fibrosis , Penyelidik Bersama , 28-07-2022 sehingga 27-12-2025 , Antarabangsa |
| A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis , Penyelidik Bersama , 18-02-2021 sehingga 17-07-2025 , Antarabangsa |
| A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacyand Safety of Mirikizumab in Patients with Moderately to Severely Active UlcerativeColitis(Protocol No.: I6T-MC-AMAP) , Penyelidik Bersama , 13-10-2019 sehingga 12-10-2024 , Antarabangsa |
| M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study To Evaluate The Efficacy And Safety Of Risankizumab In Subjects With Moderately To Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy , Penyelidik Bersama , 12-09-2019 sehingga 11-09-2024 , Antarabangsa |
| M16-066:A Multicenter,Randomized,Double-Blind,Placebo-Controlled 52-Week Maintenance And An Open Label Extension Study Of The Efficacy And Safety Of Risankizumab In Subjects With Ulcerative Colitis Who Responded To Induction Treatment In M16-067 0R 065 , Penyelidik Bersama , 12-09-2019 sehingga 11-09-2024 , Antarabangsa |
| M14-675: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis , Penyelidik Bersama , 13-06-2019 sehingga 12-06-2024 , Antarabangsa |
| A Long-Term Extension Study to Evaluate the Safety of Filgotinibin Subjects with Crohn`s Disease , Penyelidik Bersama , 16-03-2017 sehingga 15-11-2027 , Antarabangsa |
| Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn`s Disease , Penyelidik Bersama , 16-03-2017 sehingga 15-07-2024 , Antarabangsa |
| An Open-Label Extension And Safety Monitoring Study Of Moderate To Severe Ulcerative Colitis Patients Previously Enrolled In Etrolizumab Phase III Studies , Penyelidik Bersama , 26-02-2015 sehingga 25-02-2026 , Antarabangsa |
| A Randomized Controlled Trial To Determine The Effects Of A Diabetes-Specific Formula On Long-Term Glycemic Control And Short-Term Glycemic Variability In Individuals With Type 2 Diabetes , Penyelidik Bersama , 07-01-2021 sehingga 06-01-2023 , Antarabangsa |
| An Experimental Pilot Study: Safety, Feasibility And Physiological Response Of Relative Hypoglycemia To The Hormone, Heart And Brain In Type 2 Diabetes Mellitus , Penyelidik Bersama , 25-07-2020 sehingga 24-12-2021 , Universiti |
| A Randomized Controlled Trial To Determine The Effects Of Diabetes-Specific Formula On Glycemic Control In Individuals With Type 2 Diabetes , Penyelidik Bersama , 08-03-2020 sehingga 30-06-2023 , Antarabangsa |
| Randomized,24 Week,Active-Controlled,Open-Label,3-Arm.Parallel-Group Multicenter Study Comparing The Efficacy and Safety of Iglarlixi to Insulin Glargine and Lixisenatide In Type 2 Diabetes Mellitus Patients Insufficiently Controlled with Oral Antidiabet , Penyelidik Bersama , 13-09-2019 sehingga 12-07-2022 , Antarabangsa |
| A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis(Protocol No: 16T-MC-AMAN) , Penyelidik Bersama , 27-12-2018 sehingga 26-10-2023 , Antarabangsa |
| A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab In Patients with Moderately to Severely Active Ulcerative Colitis.Protocol No: 16T-MC-AMBG , Penyelidik Bersama , 27-12-2018 sehingga 26-02-2023 , Antarabangsa |
| A Multicenter, Randomized, Double-Blind, Placebo Controlled Maintenance and Long Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Crohn’s Disease who completed the M14-431 or M14-433 Studies , Penyelidik Bersama , 12-04-2018 sehingga 11-04-2023 , Antarabangsa |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn’s Disease who have Inadequately Responded to or are Intolerant to , Penyelidik Bersama , 12-04-2018 sehingga 11-04-2022 , Antarabangsa |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn`s Disease Who Have Inadequately Responded to or are Intolerant to Biologi , Penyelidik Bersama , 12-04-2018 sehingga 11-04-2022 , Antarabangsa |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn`s Disease Who Responded to Induction Treatment in M16-006 or M15-991 , Penyelidik Bersama , 26-10-2017 sehingga 25-11-2022 , Antarabangsa |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn`s Disease , Penyelidik Bersama , 14-09-2017 sehingga 13-07-2023 , Antarabangsa |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn`s Disease Who Failed Prior Biologic Treatment , Penyelidik Bersama , 14-09-2017 sehingga 13-10-2022 , Antarabangsa |
| A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis , Penyelidik Bersama , 13-04-2017 sehingga 12-12-2022 , Antarabangsa |
| Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis , Penyelidik Bersama , 13-04-2017 sehingga 12-02-2022 , Antarabangsa |
| A Phase 3 Multicenter, Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis (UC) , Penyelidik Bersama , 16-02-2017 sehingga 15-02-2023 , Antarabangsa |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis , Penyelidik Bersama , 16-02-2017 sehingga 15-02-2022 , Antarabangsa |
| The Genetics Of Adrenal Gland Diseases Causing Hyoertension , Penyelidik Bersama , 01-05-2015 sehingga 30-04-2018 , Antarabangsa |
| Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy (Induction Of Remission) And Safety Of Etrolizumab Compared With Adalimuman And Placebo In Patients With Moderate To Severe Ulcerative Coliti , Penyelidik Bersama , 26-02-2015 sehingga 25-12-2021 , Antarabangsa |
| Anugerah Perkhidmatan Cemerlang / Anugerah Perkhidmatan Cemerlang , 2013 |
| Anugerah Perkhidmatan Cemerlang / Anugerah Perkhidmatan Cemerlang , 2018 |
| AHLI JAWATAN KUASA MSQH JABATAN PERUBATAN , 16-10-2020 sehingga 02-02-2023 , Universiti |
| BENGKEL PEMANTAPAN PENERBITAN DAN PENYELIDIKAN JABATAN PERUBATAN , 15-10-2016 sehingga 01-01-1970 , Fakulti / Institut / Pusat Perkhidmatan |
| JAWATANKUASA JAMINAN KUALITI JABATAN PERUBATAN , 29-09-2017 sehingga 01-01-1970 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| JAWATANKUASA PENGURUSAN MAKMAL PEMERIKSAAN KLINIKAL 2020-2022 , 31-01-2020 sehingga 03-01-2022 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| JK PROGRAM KHIDMAT MASYARAKAT MISI BANTUAN BANJIR DI TEMERLOH PAHANG , 01-02-2021 sehingga 20-02-2021 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Jawatankuasa Penyedia Sebuharga Reagent Rental Immunoassay Unit Endokrin , 14-02-2020 sehingga 15-08-2020 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| LIAISON OFFICER , 02-01-2015 sehingga 30-12-2016 , Fakulti / Institut / Pusat Perkhidmatan |
| LIAISON OFFICER JARINGAN & PENJANAAN , 01-01-2022 sehingga 31-12-2022 , Fakulti / Institut / Pusat Perkhidmatan |
| Liaison Officer Jabatan Perubatan untuk Penyelidikan dan Penerbitan , 08-04-2016 sehingga 01-01-1970 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Liaison Officer untuk Penyelidikan dan Penerbitan , 01-01-2016 sehingga 31-12-2016 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Liason Officer (Urusetia eKhidmat & eJaringan) , 26-07-2018 sehingga 31-07-2019 , Fakulti / Institut / Pusat Perkhidmatan |
| MyRA Fakulti Perubatan UKM , 01-01-2020 sehingga 31-12-2021 , Fakulti / Institut / Pusat Perkhidmatan |
| PROGRAM KHIDMAT MASYARAKAT TAUTAN KASIH TANPA PENGHUJUNG BIL 2 , 13-06-2023 sehingga 13-06-2023 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| PROGRAM WALK A PAYUNG , 19-05-2024 sehingga 19-05-2024 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Aduan dan Khidmat Pelanggan , 08-01-2010 sehingga 01-01-1970 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Aset Jabatan Perubatan , 23-08-2013 sehingga 01-01-1970 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Aset Jabatan Perubatan , 14-08-2014 sehingga 01-01-1970 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Aset Jabatan Perubatan , 16-10-2018 sehingga 28-02-2020 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Aset Pusat Perubatan UKM , 01-12-2016 sehingga 14-02-2018 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Aset Pusat Perubatan UKM , 01-03-2018 sehingga 28-02-2020 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Aset Unit Endokrin , 30-11-2016 sehingga 01-01-1970 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Insiden PPUKM , 01-01-1970 sehingga 26-03-2015 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Insiden dan Pegawai Aset , 11-01-2012 sehingga 31-10-2014 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Laporan Jabatan Perubatan dan Makmal Pemeriksaan , 30-03-2016 sehingga 29-03-2019 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pegawai Perolehan Jabatan Perubatan, PPUKM , 18-02-2016 sehingga 01-01-1970 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Program Kualiti Jabatan Perubatan , 29-05-2014 sehingga 28-05-2016 , Pusat Pengajian / Jabatan / Pusat Penyelidikan / Unit |
| Pusat Sumber Informasi Bersepadu Pesakit , 21-02-2012 sehingga 01-01-1970 , Universiti |
| Urusetia MyRA Fakulti Perubatan , 01-01-2022 sehingga 31-12-2023 , Fakulti / Institut / Pusat Perkhidmatan |